SNDX

Syndax Pharmaceuticals Inc

Biotechnology · Biotechnology

$214.16 sample

+3.02 (+1.43%) 1D

Market cap

$920.2B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-14

Alerts

8

Price$214.16 +0.86% 3M daily closessample

224.48204.91

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: EVP, Operations
Sep 21INSInsider buy: Chief Executive Officer
Sep 14SECForm 144 filed
Sep 09INSInsider sell: Director
Aug 31INSInsider buy: Chief Financial Officer
Aug 25SECDEF 14A filed
Aug 17SECForm 144 filed
Aug 11INSInsider sell: EVP, Operations

Sign up to see the real SNDX record →

Company facts

SEC EDGAR registration

Name: Syndax Pharmaceuticals Inc
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -30sample, -100 to +100
Reporting currency: USD

Who is positioning in SNDX

sample

Insiders: 27 insider transactions over 90 days, net selling, $377.5M
Congress: No member trades over 90 days
Institutions · 13F: 6 funds hold $15.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$46.5B +18.2% y/y

Q4 2024Q3 2026

Inventory$27.9B +19.8% y/y

Q4 2024Q3 2026

Accounts receivable$20.5B +19.2% y/y

Q4 2024Q3 2026

Total debt$54.3B +18.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $733.3B -6.1% 3M
Sample peer B: $138.1B -9.7% 3M
Sample peer C: $883.0B +15.9% 3M
Sample peer D: $457.4B +14.8% 3M
Sample peer E: $748.2B +8.7% 3M